Pre-surgery romiplostim for patients with low platelets having heart surgery
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests if giving romiplostim before heart surgery can safely increase low platelet counts. It may help patients with low platelets avoid bleeding complications during and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) having heart surgery that uses a heart-lung machine.
- Your platelet count is below 150,000 before surgery.
- You can receive the first study injection 10 to 14 days before your surgery.
- You will need to take blood thinners for at least one month after surgery.
- You do not have a bleeding disorder like hemophilia or a history of blood clots or stroke.
- You are not pregnant, breastfeeding, or taking certain medications that could interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called romiplostim for patients whose platelet counts stay very low (below 30) for a long time after chemotherapy, even after other treatments have failed. The goal is to see if romiplostim can help raise your platelet count to a safer level.
This trial tests if romiplostim, a drug that helps the body make platelets, can speed up platelet recovery after a special type of stem cell transplant from a half-matched donor. It may help reduce bleeding risk during the recovery period.
This trial tests a new form of romiplostim (a drug that boosts platelets) in breast cancer patients whose platelet counts have dropped due to chemotherapy. It aims to see if it can safely raise platelet levels to reduce bleeding risk and allow chemo to continue.
This study tests a new drug called romiplostim N01 to help raise platelet counts in patients with sepsis (a serious blood infection). Low platelets during sepsis can increase bleeding risk, and this drug may help prevent complications.
This study tests a medicine called romiplostim N01 to see if it can prevent low platelet counts caused by chemotherapy in breast cancer patients. It may help reduce the risk of bleeding and allow you to complete your chemotherapy on time.
This trial tests whether the drug hetrombopag can safely raise platelet counts in people with immune thrombocytopenia (ITP) before they have surgery. The goal is to reduce bleeding risk during and after the operation.
Hear when a new Chirurgical Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.